Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…
Search results for: hospital

Pediatric to Adult Care Transition Challenging for Patients with JIA
Dr. Sheffield is an adult rheumatologist who received the following referral request from a family doctor: “Please see this 22-year-old male with a history of juvenile arthritis for ongoing care. I have only seen him once, and have no previous medical records.” Dr. Sheffield meets with Paul, who reports that he has had arthritis since…

Physicians as Targets of Medical Workplace Violence
Tuesday, Jan. 20, a busy morning lay ahead for the staff of the cardiovascular surgery clinic. There were several new patients to see. No doubt, many of them were anxious to hear whether the skills of the surgeons they were going to meet could help them live another day. There were countless follow-up visits and…

Rheumatologist Recalls Personal Experience with RA
In late March 2012, I awoke with pain in my left hand. I had difficulty moving my metacarpophalangeal (MCP) joints. They did not move smoothly, but clunked. As I repeatedly attempted to open and close my hand, I realized that I had morning stiffness. As the pain and stiffness gradually improved over the next hour,…

Melioidosis: What Rheumatologists Need to Know
Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and northern Australia.1 In recent years, the incidence of melioidosis has increased worldwide. Septic arthritis is a rare, but well-recognized, manifestation of melioidosis. Case Report A 49-year-old woman with known diabetes was admitted elsewhere with uncontrolled diabetes and fever. She was found to…

Rheumatologists Expand Reach Through Telemedicine
What started out as a way to bring specialty medicine to rural areas around 40 years ago has evolved from sharing imaging and laboratory results to seeing and interacting with patients remotely. Telemedicine is beginning to evolve from its traditional urban–rural linkage, and rheumatologists are following along. “Telemedicine covers a variety of services, but it…

Psoriatic Arthritis: Recognize, Manage Comorbidities
As the literature on comorbidities linked to psoriatic arthritis (PsA) expands, it’s becoming more difficult for clinicians to keep up with what comorbidities should be assessed and how these comorbidities affect treatment selection. Given this, rheumatologists at the Perelman School of Medicine at University of Pennsylvania, Cleveland Clinic and Hospital for Special Surgery in New…

Rheumatologists on the Move
Maura Daly Iversen Named Catherine Worthingham Fellow by APTA Maura Daly Iversen, PT, DPT, SD, MPH, FNAP, FAPTA, associate editor of The Rheumatologist, was recently named a Catherine Worthingham Fellow—the highest honor among the American Physical Therapy Association (APTA) membership categories. According to the award announcement, Worthingham “motivated others to make an impact within the…

Rheumatologist Sidney R. Block, MD, Relishes Role as Cantor
Sidney R. Block, MD, has practiced rheumatology in Maine since 1975, where he now lives on the coast in Northport. He has received the Paulding Phelps Award and been recognized as a Master by the American College of Rheumatology. He is also a lay cantor for the Jewish reform congregation in Bangor, which he helped…
First Biosimilar Drugs Approved in U.S., Canada
The first biosmilar products have been approved in the U.S. and Canada, following Europe’s early lead. Canada approved its first biosimilar monoclonal antibody (mAb) therapy, known as Inflectra (infliximab), on March 30, 2015.1 In Canada, biosimilars are being called subsequent entry biologic (SEB) agents. Inflectra is approved for treating patients with rheumatoid arthritis (RA), ankylosing…
- « Previous Page
- 1
- …
- 251
- 252
- 253
- 254
- 255
- …
- 331
- Next Page »